Global Imatinib Drugs Industry Research Report, Competitive Landscape, Market Size, Regional Status and Prospect
The report combines extensive quantitative analysis and exhaustive qualitative analysis, ranges from a macro overview of the total market size, industry chain, and market dynamics to micro details of segment markets by type, application and region, and, as a result, provides a holistic view of, as well as a deep insight into the Imatinib Drugs market covering all its essential aspects.
For the competitive landscape, the report also introduces players in the industry from the perspective of the market share, concentration ratio, etc., and describes the leading companies in detail, with which the readers can get a better idea of their competitors and acquire an in-depth understanding of the competitive situation. Further, mergers & acquisitions, emerging market trends, the impact of COVID-19, and regional conflicts will all be considered.
In a nutshell, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the market in any manner.
Key players in the global Imatinib Drugs market are covered in Chapter 9:
Sanofi S.A.
Sun Pharmaceuticals
Novartis
Apotex Inc.
Dr. Reddy's Laboratories
Mylan Pharms Inc.
Glenmark Pharmaceuticals Ltd.
Teva Pharmaceutical Industries Ltd.
Actavis Generics
Cipla Inc.
In Chapter 5 and Chapter 7.3, based on types, the Imatinib Drugs market from 2017 to 2027 is primarily split into:
Capsules
Tablets
In Chapter 6 and Chapter 7.4, based on applications, the Imatinib Drugs market from 2017 to 2027 covers:
Aggressive Systemic Mastocytosis (ASM)
Chronic Eosinophilic Leukemia (CEL)
Dermatofibrosarcoma Protuberans (DFSP)
Gastrointestinal Stromal Tumors (GIST)
Hyper-eosinophilic Syndrome (HES)
Myelodysplastic Syndrome (MDS)
Myeloproliferative Diseases (MPD)
Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia (Ph+ ALL)
Philadelphia Chromosome-positive Chronic Myeloid Leukemia (Ph+ CML)
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2017-2027) of the following regions are covered in Chapter 4 and Chapter 7:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Client Focus
1. Does this report consider the impact of COVID-19 and the Russia-Ukraine war on the Imatinib Drugs market?
Yes. As the COVID-19 and the Russia-Ukraine war are profoundly affecting the global supply chain relationship and raw material price system, we have definitely taken them into consideration throughout the research, and in Chapters 1.7, 2.7, 4.X.1, 7.5, 8.7, we elaborate at full length on the impact of the pandemic and the war on the Imatinib Drugs Industry.
2. How do you determine the list of the key players included in the report?
With the aim of clearly revealing the competitive situation of the industry, we concretely analyze not only the leading enterprises that have a voice on a global scale, but also the regional small and medium-sized companies that play key roles and have plenty of potential growth.
Please find the key player list in Summary.
3. What are your main data sources?
Both Primary and Secondary data sources are being used while compiling the report.
Primary sources include extensive interviews of key opinion leaders and industry experts (such as experienced front-line staff, directors, CEOs, and marketing executives), downstream distributors, as well as end-users.
Secondary sources include the research of the annual and financial reports of the top companies, public files, new journals, etc. We also cooperate with some third-party databases.
Please find a more complete list of data sources in Chapters 11.2.1 & 11.2.2.
4. Can I modify the scope of the report and customize it to suit my requirements?
Yes. Customized requirements of multi-dimensional, deep-level and high-quality can help our customers precisely grasp market opportunities, effortlessly confront market challenges, properly formulate market strategies and act promptly, thus to win them sufficient time and space for market competition.
Outline
Chapter 1 mainly defines the market scope and introduces the macro overview of the industry, with an executive summary of different market segments ((by type, application, region, etc.), including the definition, market size, and trend of each market segment.
Chapter 2 provides a qualitative analysis of the current status and future trends of the market. Industry Entry Barriers, market drivers, market challenges, emerging markets, consumer preference analysis, together with the impact of the COVID-19 outbreak will all be thoroughly explained.
Chapter 3 analyzes the current competitive situation of the market by providing data regarding the players, including their sales volume and revenue with corresponding market shares, price and gross margin. In addition, information about market concentration ratio, mergers, acquisitions, and expansion plans will also be covered.
Chapter 4 focuses on the regional market, presenting detailed data (i.e., sales volume, revenue, price, gross margin) of the most representative regions and countries in the world.
Chapter 5 provides the analysis of various market segments according to product types, covering sales volume, revenue along with market share and growth rate, plus the price analysis of each type.
Chapter 6 shows the breakdown data of different applications, including the consumption and revenue with market share and growth rate, with the aim of helping the readers to take a close-up look at the downstream market.
Chapter 7 provides a combination of quantitative and qualitative analyses of the market size and development trends in the next five years. The forecast information of the whole, as well as the breakdown market, offers the readers a chance to look into the future of the industry.
Chapter 8 is the analysis of the whole market industrial chain, covering key raw materials suppliers and price analysis, manufacturing cost structure analysis, alternative product analysis, also providing information on major distributors, downstream buyers, and the impact of COVID-19 pandemic.
Chapter 9 shares a list of the key players in the market, together with their basic information, product profiles, market performance (i.e., sales volume, price, revenue, gross margin), recent development, SWOT analysis, etc.
Chapter 10 is the conclusion of the report which helps the readers to sum up the main findings and points.
Chapter 11 introduces the market research methods and data sources.
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2027
1 IMATINIB DRUGS MARKET OVERVIEW
1.1 Product Overview and Scope of Imatinib Drugs Market
1.2 Imatinib Drugs Market Segment by Type
1.2.1 Global Imatinib Drugs Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Imatinib Drugs Market Segment by Application
1.3.1 Imatinib Drugs Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Imatinib Drugs Market, Region Wise (2017-2027)
1.4.1 Global Imatinib Drugs Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
1.4.2 United States Imatinib Drugs Market Status and Prospect (2017-2027)
1.4.3 Europe Imatinib Drugs Market Status and Prospect (2017-2027)
1.4.4 China Imatinib Drugs Market Status and Prospect (2017-2027)
1.4.5 Japan Imatinib Drugs Market Status and Prospect (2017-2027)
1.4.6 India Imatinib Drugs Market Status and Prospect (2017-2027)
1.4.7 Southeast Asia Imatinib Drugs Market Status and Prospect (2017-2027)
1.4.8 Latin America Imatinib Drugs Market Status and Prospect (2017-2027)
1.4.9 Middle East and Africa Imatinib Drugs Market Status and Prospect (2017-2027)
1.5 Global Market Size of Imatinib Drugs (2017-2027)
1.5.1 Global Imatinib Drugs Market Revenue Status and Outlook (2017-2027)
1.5.2 Global Imatinib Drugs Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Imatinib Drugs Market
2 INDUSTRY OUTLOOK
2.1 Imatinib Drugs Industry Technology Status and Trends
2.2 Industry Entry Barriers
2.2.1 Analysis of Financial Barriers
2.2.2 Analysis of Technical Barriers
2.2.3 Analysis of Talent Barriers
2.2.4 Analysis of Brand Barrier
2.3 Imatinib Drugs Market Drivers Analysis
2.4 Imatinib Drugs Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Imatinib Drugs Industry Development Trends under COVID-19 Outbreak
2.7.1 Global COVID-19 Status Overview
2.7.2 Influence of COVID-19 Outbreak on Imatinib Drugs Industry Development
3 GLOBAL IMATINIB DRUGS MARKET LANDSCAPE BY PLAYER
3.1 Global Imatinib Drugs Sales Volume and Share by Player (2017-2022)
3.2 Global Imatinib Drugs Revenue and Market Share by Player (2017-2022)
3.3 Global Imatinib Drugs Average Price by Player (2017-2022)
3.4 Global Imatinib Drugs Gross Margin by Player (2017-2022)
3.5 Imatinib Drugs Market Competitive Situation and Trends
3.5.1 Imatinib Drugs Market Concentration Rate
3.5.2 Imatinib Drugs Market Share of Top 3 and Top 6 Players
3.5.3 Mergers & Acquisitions, Expansion
4 GLOBAL IMATINIB DRUGS SALES VOLUME AND REVENUE REGION WISE (2017-2022)
4.1 Global Imatinib Drugs Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Imatinib Drugs Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Imatinib Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Imatinib Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4.1 United States Imatinib Drugs Market Under COVID-19
4.5 Europe Imatinib Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.5.1 Europe Imatinib Drugs Market Under COVID-19
4.6 China Imatinib Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.6.1 China Imatinib Drugs Market Under COVID-19
4.7 Japan Imatinib Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.7.1 Japan Imatinib Drugs Market Under COVID-19
4.8 India Imatinib Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.8.1 India Imatinib Drugs Market Under COVID-19
4.9 Southeast Asia Imatinib Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.9.1 Southeast Asia Imatinib Drugs Market Under COVID-19
4.10 Latin America Imatinib Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.10.1 Latin America Imatinib Drugs Market Under COVID-19
4.11 Middle East and Africa Imatinib Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.11.1 Middle East and Africa Imatinib Drugs Market Under COVID-19
5 GLOBAL IMATINIB DRUGS SALES VOLUME, REVENUE, PRICE TREND BY TYPE
5.1 Global Imatinib Drugs Sales Volume and Market Share by Type (2017-2022)
5.2 Global Imatinib Drugs Revenue and Market Share by Type (2017-2022)
5.3 Global Imatinib Drugs Price by Type (2017-2022)
5.4 Global Imatinib Drugs Sales Volume, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Imatinib Drugs Sales Volume, Revenue and Growth Rate of Capsules (2017-2022)
5.4.2 Global Imatinib Drugs Sales Volume, Revenue and Growth Rate of Tablets (2017-2022)
6 GLOBAL IMATINIB DRUGS MARKET ANALYSIS BY APPLICATION
6.1 Global Imatinib Drugs Consumption and Market Share by Application (2017-2022)
6.2 Global Imatinib Drugs Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Imatinib Drugs Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Imatinib Drugs Consumption and Growth Rate of Aggressive Systemic Mastocytosis (ASM) (2017-2022)
6.3.2 Global Imatinib Drugs Consumption and Growth Rate of Chronic Eosinophilic Leukemia (CEL) (2017-2022)
6.3.3 Global Imatinib Drugs Consumption and Growth Rate of Dermatofibrosarcoma Protuberans (DFSP) (2017-2022)
6.3.4 Global Imatinib Drugs Consumption and Growth Rate of Gastrointestinal Stromal Tumors (GIST) (2017-2022)
6.3.5 Global Imatinib Drugs Consumption and Growth Rate of Hyper-eosinophilic Syndrome (HES) (2017-2022)
6.3.6 Global Imatinib Drugs Consumption and Growth Rate of Myelodysplastic Syndrome (MDS) (2017-2022)
6.3.7 Global Imatinib Drugs Consumption and Growth Rate of Myeloproliferative Diseases (MPD) (2017-2022)
6.3.8 Global Imatinib Drugs Consumption and Growth Rate of Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia (Ph+ ALL) (2017-2022)
6.3.9 Global Imatinib Drugs Consumption and Growth Rate of Philadelphia Chromosome-positive Chronic Myeloid Leukemia (Ph+ CML) (2017-2022)
7 GLOBAL IMATINIB DRUGS MARKET FORECAST (2022-2027)
7.1 Global Imatinib Drugs Sales Volume, Revenue Forecast (2022-2027)
7.1.1 Global Imatinib Drugs Sales Volume and Growth Rate Forecast (2022-2027)
7.1.2 Global Imatinib Drugs Revenue and Growth Rate Forecast (2022-2027)
7.1.3 Global Imatinib Drugs Price and Trend Forecast (2022-2027)
7.2 Global Imatinib Drugs Sales Volume and Revenue Forecast, Region Wise (2022-2027)
7.2.1 United States Imatinib Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.2 Europe Imatinib Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.3 China Imatinib Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.4 Japan Imatinib Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.5 India Imatinib Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.6 Southeast Asia Imatinib Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.7 Latin America Imatinib Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.8 Middle East and Africa Imatinib Drugs Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Imatinib Drugs Sales Volume, Revenue and Price Forecast by Type (2022-2027)
7.3.1 Global Imatinib Drugs Revenue and Growth Rate of Capsules (2022-2027)
7.3.2 Global Imatinib Drugs Revenue and Growth Rate of Tablets (2022-2027)
7.4 Global Imatinib Drugs Consumption Forecast by Application (2022-2027)
7.4.1 Global Imatinib Drugs Consumption Value and Growth Rate of Aggressive Systemic Mastocytosis (ASM)(2022-2027)
7.4.2 Global Imatinib Drugs Consumption Value and Growth Rate of Chronic Eosinophilic Leukemia (CEL)(2022-2027)
7.4.3 Global Imatinib Drugs Consumption Value and Growth Rate of Dermatofibrosarcoma Protuberans (DFSP)(2022-2027)
7.4.4 Global Imatinib Drugs Consumption Value and Growth Rate of Gastrointestinal Stromal Tumors (GIST)(2022-2027)
7.4.5 Global Imatinib Drugs Consumption Value and Growth Rate of Hyper-eosinophilic Syndrome (HES)(2022-2027)
7.4.6 Global Imatinib Drugs Consumption Value and Growth Rate of Myelodysplastic Syndrome (MDS)(2022-2027)
7.4.7 Global Imatinib Drugs Consumption Value and Growth Rate of Myeloproliferative Diseases (MPD)(2022-2027)
7.4.8 Global Imatinib Drugs Consumption Value and Growth Rate of Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia (Ph+ ALL)(2022-2027)
7.4.9 Global Imatinib Drugs Consumption Value and Growth Rate of Philadelphia Chromosome-positive Chronic Myeloid Leukemia (Ph+ CML)(2022-2027)
7.5 Imatinib Drugs Market Forecast Under COVID-19
8 IMATINIB DRUGS MARKET UPSTREAM AND DOWNSTREAM ANALYSIS
8.1 Imatinib Drugs Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
8.3.1 Labor Cost Analysis
8.3.2 Energy Costs Analysis
8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Imatinib Drugs Analysis
8.6 Major Downstream Buyers of Imatinib Drugs Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Imatinib Drugs Industry
9 PLAYERS PROFILES
9.1 Sanofi S.A.
9.1.1 Sanofi S.A. Basic Information, Manufacturing Base, Sales Region and Competitors
9.1.2 Imatinib Drugs Product Profiles, Application and Specification
9.1.3 Sanofi S.A. Market Performance (2017-2022)
9.1.4 Recent Development
9.1.5 SWOT Analysis
9.2 Sun Pharmaceuticals
9.2.1 Sun Pharmaceuticals Basic Information, Manufacturing Base, Sales Region and Competitors
9.2.2 Imatinib Drugs Product Profiles, Application and Specification
9.2.3 Sun Pharmaceuticals Market Performance (2017-2022)
9.2.4 Recent Development
9.2.5 SWOT Analysis
9.3 Novartis
9.3.1 Novartis Basic Information, Manufacturing Base, Sales Region and Competitors
9.3.2 Imatinib Drugs Product Profiles, Application and Specification
9.3.3 Novartis Market Performance (2017-2022)
9.3.4 Recent Development
9.3.5 SWOT Analysis
9.4 Apotex Inc.
9.4.1 Apotex Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.4.2 Imatinib Drugs Product Profiles, Application and Specification
9.4.3 Apotex Inc. Market Performance (2017-2022)
9.4.4 Recent Development
9.4.5 SWOT Analysis
9.5 Dr. Reddy's Laboratories
9.5.1 Dr. Reddy's Laboratories Basic Information, Manufacturing Base, Sales Region and Competitors
9.5.2 Imatinib Drugs Product Profiles, Application and Specification
9.5.3 Dr. Reddy's Laboratories Market Performance (2017-2022)
9.5.4 Recent Development
9.5.5 SWOT Analysis
9.6 Mylan Pharms Inc.
9.6.1 Mylan Pharms Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.6.2 Imatinib Drugs Product Profiles, Application and Specification
9.6.3 Mylan Pharms Inc. Market Performance (2017-2022)
9.6.4 Recent Development
9.6.5 SWOT Analysis
9.7 Glenmark Pharmaceuticals Ltd.
9.7.1 Glenmark Pharmaceuticals Ltd. Basic Information, Manufacturing Base, Sales Region and Competitors
9.7.2 Imatinib Drugs Product Profiles, Application and Specification
9.7.3 Glenmark Pharmaceuticals Ltd. Market Performance (2017-2022)
9.7.4 Recent Development
9.7.5 SWOT Analysis
9.8 Teva Pharmaceutical Industries Ltd.
9.8.1 Teva Pharmaceutical Industries Ltd. Basic Information, Manufacturing Base, Sales Region and Competitors
9.8.2 Imatinib Drugs Product Profiles, Application and Specification
9.8.3 Teva Pharmaceutical Industries Ltd. Market Performance (2017-2022)
9.8.4 Recent Development
9.8.5 SWOT Analysis
9.9 Actavis Generics
9.9.1 Actavis Generics Basic Information, Manufacturing Base, Sales Region and Competitors
9.9.2 Imatinib Drugs Product Profiles, Application and Specification
9.9.3 Actavis Generics Market Performance (2017-2022)
9.9.4 Recent Development
9.9.5 SWOT Analysis
9.10 Cipla Inc.
9.10.1 Cipla Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.10.2 Imatinib Drugs Product Profiles, Application and Specification
9.10.3 Cipla Inc. Market Performance (2017-2022)
9.10.4 Recent Development
9.10.5 SWOT Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Data Source
1.1 Product Overview and Scope of Imatinib Drugs Market
1.2 Imatinib Drugs Market Segment by Type
1.2.1 Global Imatinib Drugs Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Imatinib Drugs Market Segment by Application
1.3.1 Imatinib Drugs Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Imatinib Drugs Market, Region Wise (2017-2027)
1.4.1 Global Imatinib Drugs Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
1.4.2 United States Imatinib Drugs Market Status and Prospect (2017-2027)
1.4.3 Europe Imatinib Drugs Market Status and Prospect (2017-2027)
1.4.4 China Imatinib Drugs Market Status and Prospect (2017-2027)
1.4.5 Japan Imatinib Drugs Market Status and Prospect (2017-2027)
1.4.6 India Imatinib Drugs Market Status and Prospect (2017-2027)
1.4.7 Southeast Asia Imatinib Drugs Market Status and Prospect (2017-2027)
1.4.8 Latin America Imatinib Drugs Market Status and Prospect (2017-2027)
1.4.9 Middle East and Africa Imatinib Drugs Market Status and Prospect (2017-2027)
1.5 Global Market Size of Imatinib Drugs (2017-2027)
1.5.1 Global Imatinib Drugs Market Revenue Status and Outlook (2017-2027)
1.5.2 Global Imatinib Drugs Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Imatinib Drugs Market
2 INDUSTRY OUTLOOK
2.1 Imatinib Drugs Industry Technology Status and Trends
2.2 Industry Entry Barriers
2.2.1 Analysis of Financial Barriers
2.2.2 Analysis of Technical Barriers
2.2.3 Analysis of Talent Barriers
2.2.4 Analysis of Brand Barrier
2.3 Imatinib Drugs Market Drivers Analysis
2.4 Imatinib Drugs Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Imatinib Drugs Industry Development Trends under COVID-19 Outbreak
2.7.1 Global COVID-19 Status Overview
2.7.2 Influence of COVID-19 Outbreak on Imatinib Drugs Industry Development
3 GLOBAL IMATINIB DRUGS MARKET LANDSCAPE BY PLAYER
3.1 Global Imatinib Drugs Sales Volume and Share by Player (2017-2022)
3.2 Global Imatinib Drugs Revenue and Market Share by Player (2017-2022)
3.3 Global Imatinib Drugs Average Price by Player (2017-2022)
3.4 Global Imatinib Drugs Gross Margin by Player (2017-2022)
3.5 Imatinib Drugs Market Competitive Situation and Trends
3.5.1 Imatinib Drugs Market Concentration Rate
3.5.2 Imatinib Drugs Market Share of Top 3 and Top 6 Players
3.5.3 Mergers & Acquisitions, Expansion
4 GLOBAL IMATINIB DRUGS SALES VOLUME AND REVENUE REGION WISE (2017-2022)
4.1 Global Imatinib Drugs Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Imatinib Drugs Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Imatinib Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Imatinib Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4.1 United States Imatinib Drugs Market Under COVID-19
4.5 Europe Imatinib Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.5.1 Europe Imatinib Drugs Market Under COVID-19
4.6 China Imatinib Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.6.1 China Imatinib Drugs Market Under COVID-19
4.7 Japan Imatinib Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.7.1 Japan Imatinib Drugs Market Under COVID-19
4.8 India Imatinib Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.8.1 India Imatinib Drugs Market Under COVID-19
4.9 Southeast Asia Imatinib Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.9.1 Southeast Asia Imatinib Drugs Market Under COVID-19
4.10 Latin America Imatinib Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.10.1 Latin America Imatinib Drugs Market Under COVID-19
4.11 Middle East and Africa Imatinib Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.11.1 Middle East and Africa Imatinib Drugs Market Under COVID-19
5 GLOBAL IMATINIB DRUGS SALES VOLUME, REVENUE, PRICE TREND BY TYPE
5.1 Global Imatinib Drugs Sales Volume and Market Share by Type (2017-2022)
5.2 Global Imatinib Drugs Revenue and Market Share by Type (2017-2022)
5.3 Global Imatinib Drugs Price by Type (2017-2022)
5.4 Global Imatinib Drugs Sales Volume, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Imatinib Drugs Sales Volume, Revenue and Growth Rate of Capsules (2017-2022)
5.4.2 Global Imatinib Drugs Sales Volume, Revenue and Growth Rate of Tablets (2017-2022)
6 GLOBAL IMATINIB DRUGS MARKET ANALYSIS BY APPLICATION
6.1 Global Imatinib Drugs Consumption and Market Share by Application (2017-2022)
6.2 Global Imatinib Drugs Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Imatinib Drugs Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Imatinib Drugs Consumption and Growth Rate of Aggressive Systemic Mastocytosis (ASM) (2017-2022)
6.3.2 Global Imatinib Drugs Consumption and Growth Rate of Chronic Eosinophilic Leukemia (CEL) (2017-2022)
6.3.3 Global Imatinib Drugs Consumption and Growth Rate of Dermatofibrosarcoma Protuberans (DFSP) (2017-2022)
6.3.4 Global Imatinib Drugs Consumption and Growth Rate of Gastrointestinal Stromal Tumors (GIST) (2017-2022)
6.3.5 Global Imatinib Drugs Consumption and Growth Rate of Hyper-eosinophilic Syndrome (HES) (2017-2022)
6.3.6 Global Imatinib Drugs Consumption and Growth Rate of Myelodysplastic Syndrome (MDS) (2017-2022)
6.3.7 Global Imatinib Drugs Consumption and Growth Rate of Myeloproliferative Diseases (MPD) (2017-2022)
6.3.8 Global Imatinib Drugs Consumption and Growth Rate of Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia (Ph+ ALL) (2017-2022)
6.3.9 Global Imatinib Drugs Consumption and Growth Rate of Philadelphia Chromosome-positive Chronic Myeloid Leukemia (Ph+ CML) (2017-2022)
7 GLOBAL IMATINIB DRUGS MARKET FORECAST (2022-2027)
7.1 Global Imatinib Drugs Sales Volume, Revenue Forecast (2022-2027)
7.1.1 Global Imatinib Drugs Sales Volume and Growth Rate Forecast (2022-2027)
7.1.2 Global Imatinib Drugs Revenue and Growth Rate Forecast (2022-2027)
7.1.3 Global Imatinib Drugs Price and Trend Forecast (2022-2027)
7.2 Global Imatinib Drugs Sales Volume and Revenue Forecast, Region Wise (2022-2027)
7.2.1 United States Imatinib Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.2 Europe Imatinib Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.3 China Imatinib Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.4 Japan Imatinib Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.5 India Imatinib Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.6 Southeast Asia Imatinib Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.7 Latin America Imatinib Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.8 Middle East and Africa Imatinib Drugs Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Imatinib Drugs Sales Volume, Revenue and Price Forecast by Type (2022-2027)
7.3.1 Global Imatinib Drugs Revenue and Growth Rate of Capsules (2022-2027)
7.3.2 Global Imatinib Drugs Revenue and Growth Rate of Tablets (2022-2027)
7.4 Global Imatinib Drugs Consumption Forecast by Application (2022-2027)
7.4.1 Global Imatinib Drugs Consumption Value and Growth Rate of Aggressive Systemic Mastocytosis (ASM)(2022-2027)
7.4.2 Global Imatinib Drugs Consumption Value and Growth Rate of Chronic Eosinophilic Leukemia (CEL)(2022-2027)
7.4.3 Global Imatinib Drugs Consumption Value and Growth Rate of Dermatofibrosarcoma Protuberans (DFSP)(2022-2027)
7.4.4 Global Imatinib Drugs Consumption Value and Growth Rate of Gastrointestinal Stromal Tumors (GIST)(2022-2027)
7.4.5 Global Imatinib Drugs Consumption Value and Growth Rate of Hyper-eosinophilic Syndrome (HES)(2022-2027)
7.4.6 Global Imatinib Drugs Consumption Value and Growth Rate of Myelodysplastic Syndrome (MDS)(2022-2027)
7.4.7 Global Imatinib Drugs Consumption Value and Growth Rate of Myeloproliferative Diseases (MPD)(2022-2027)
7.4.8 Global Imatinib Drugs Consumption Value and Growth Rate of Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia (Ph+ ALL)(2022-2027)
7.4.9 Global Imatinib Drugs Consumption Value and Growth Rate of Philadelphia Chromosome-positive Chronic Myeloid Leukemia (Ph+ CML)(2022-2027)
7.5 Imatinib Drugs Market Forecast Under COVID-19
8 IMATINIB DRUGS MARKET UPSTREAM AND DOWNSTREAM ANALYSIS
8.1 Imatinib Drugs Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
8.3.1 Labor Cost Analysis
8.3.2 Energy Costs Analysis
8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Imatinib Drugs Analysis
8.6 Major Downstream Buyers of Imatinib Drugs Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Imatinib Drugs Industry
9 PLAYERS PROFILES
9.1 Sanofi S.A.
9.1.1 Sanofi S.A. Basic Information, Manufacturing Base, Sales Region and Competitors
9.1.2 Imatinib Drugs Product Profiles, Application and Specification
9.1.3 Sanofi S.A. Market Performance (2017-2022)
9.1.4 Recent Development
9.1.5 SWOT Analysis
9.2 Sun Pharmaceuticals
9.2.1 Sun Pharmaceuticals Basic Information, Manufacturing Base, Sales Region and Competitors
9.2.2 Imatinib Drugs Product Profiles, Application and Specification
9.2.3 Sun Pharmaceuticals Market Performance (2017-2022)
9.2.4 Recent Development
9.2.5 SWOT Analysis
9.3 Novartis
9.3.1 Novartis Basic Information, Manufacturing Base, Sales Region and Competitors
9.3.2 Imatinib Drugs Product Profiles, Application and Specification
9.3.3 Novartis Market Performance (2017-2022)
9.3.4 Recent Development
9.3.5 SWOT Analysis
9.4 Apotex Inc.
9.4.1 Apotex Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.4.2 Imatinib Drugs Product Profiles, Application and Specification
9.4.3 Apotex Inc. Market Performance (2017-2022)
9.4.4 Recent Development
9.4.5 SWOT Analysis
9.5 Dr. Reddy's Laboratories
9.5.1 Dr. Reddy's Laboratories Basic Information, Manufacturing Base, Sales Region and Competitors
9.5.2 Imatinib Drugs Product Profiles, Application and Specification
9.5.3 Dr. Reddy's Laboratories Market Performance (2017-2022)
9.5.4 Recent Development
9.5.5 SWOT Analysis
9.6 Mylan Pharms Inc.
9.6.1 Mylan Pharms Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.6.2 Imatinib Drugs Product Profiles, Application and Specification
9.6.3 Mylan Pharms Inc. Market Performance (2017-2022)
9.6.4 Recent Development
9.6.5 SWOT Analysis
9.7 Glenmark Pharmaceuticals Ltd.
9.7.1 Glenmark Pharmaceuticals Ltd. Basic Information, Manufacturing Base, Sales Region and Competitors
9.7.2 Imatinib Drugs Product Profiles, Application and Specification
9.7.3 Glenmark Pharmaceuticals Ltd. Market Performance (2017-2022)
9.7.4 Recent Development
9.7.5 SWOT Analysis
9.8 Teva Pharmaceutical Industries Ltd.
9.8.1 Teva Pharmaceutical Industries Ltd. Basic Information, Manufacturing Base, Sales Region and Competitors
9.8.2 Imatinib Drugs Product Profiles, Application and Specification
9.8.3 Teva Pharmaceutical Industries Ltd. Market Performance (2017-2022)
9.8.4 Recent Development
9.8.5 SWOT Analysis
9.9 Actavis Generics
9.9.1 Actavis Generics Basic Information, Manufacturing Base, Sales Region and Competitors
9.9.2 Imatinib Drugs Product Profiles, Application and Specification
9.9.3 Actavis Generics Market Performance (2017-2022)
9.9.4 Recent Development
9.9.5 SWOT Analysis
9.10 Cipla Inc.
9.10.1 Cipla Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.10.2 Imatinib Drugs Product Profiles, Application and Specification
9.10.3 Cipla Inc. Market Performance (2017-2022)
9.10.4 Recent Development
9.10.5 SWOT Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Data Source
LIST OF TABLES AND FIGURES
Figure Imatinib Drugs Product Picture
Table Global Imatinib Drugs Market Sales Volume and CAGR (%) Comparison by Type
Table Imatinib Drugs Market Consumption (Sales Volume) Comparison by Application (2017-2027)
Figure Global Imatinib Drugs Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)
Figure United States Imatinib Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Europe Imatinib Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Imatinib Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Imatinib Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Imatinib Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Imatinib Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Latin America Imatinib Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Middle East and Africa Imatinib Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Global Imatinib Drugs Market Sales Volume Status and Outlook (2017-2027)
Table Global Macroeconomic Analysis
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Imatinib Drugs Industry Development
Table Global Imatinib Drugs Sales Volume by Player (2017-2022)
Table Global Imatinib Drugs Sales Volume Share by Player (2017-2022)
Figure Global Imatinib Drugs Sales Volume Share by Player in 2021
Table Imatinib Drugs Revenue (Million USD) by Player (2017-2022)
Table Imatinib Drugs Revenue Market Share by Player (2017-2022)
Table Imatinib Drugs Price by Player (2017-2022)
Table Imatinib Drugs Gross Margin by Player (2017-2022)
Table Mergers & Acquisitions, Expansion Plans
Table Global Imatinib Drugs Sales Volume, Region Wise (2017-2022)
Table Global Imatinib Drugs Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Imatinib Drugs Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Imatinib Drugs Sales Volume Market Share, Region Wise in 2021
Table Global Imatinib Drugs Revenue (Million USD), Region Wise (2017-2022)
Table Global Imatinib Drugs Revenue Market Share, Region Wise (2017-2022)
Figure Global Imatinib Drugs Revenue Market Share, Region Wise (2017-2022)
Figure Global Imatinib Drugs Revenue Market Share, Region Wise in 2021
Table Global Imatinib Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table United States Imatinib Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Europe Imatinib Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table China Imatinib Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Japan Imatinib Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table India Imatinib Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Southeast Asia Imatinib Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Latin America Imatinib Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Middle East and Africa Imatinib Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Global Imatinib Drugs Sales Volume by Type (2017-2022)
Table Global Imatinib Drugs Sales Volume Market Share by Type (2017-2022)
Figure Global Imatinib Drugs Sales Volume Market Share by Type in 2021
Table Global Imatinib Drugs Revenue (Million USD) by Type (2017-2022)
Table Global Imatinib Drugs Revenue Market Share by Type (2017-2022)
Figure Global Imatinib Drugs Revenue Market Share by Type in 2021
Table Imatinib Drugs Price by Type (2017-2022)
Figure Global Imatinib Drugs Sales Volume and Growth Rate of Capsules (2017-2022)
Figure Global Imatinib Drugs Revenue (Million USD) and Growth Rate of Capsules (2017-2022)
Figure Global Imatinib Drugs Sales Volume and Growth Rate of Tablets (2017-2022)
Figure Global Imatinib Drugs Revenue (Million USD) and Growth Rate of Tablets (2017-2022)
Table Global Imatinib Drugs Consumption by Application (2017-2022)
Table Global Imatinib Drugs Consumption Market Share by Application (2017-2022)
Table Global Imatinib Drugs Consumption Revenue (Million USD) by Application (2017-2022)
Table Global Imatinib Drugs Consumption Revenue Market Share by Application (2017-2022)
Table Global Imatinib Drugs Consumption and Growth Rate of Aggressive Systemic Mastocytosis (ASM) (2017-2022)
Table Global Imatinib Drugs Consumption and Growth Rate of Chronic Eosinophilic Leukemia (CEL) (2017-2022)
Table Global Imatinib Drugs Consumption and Growth Rate of Dermatofibrosarcoma Protuberans (DFSP) (2017-2022)
Table Global Imatinib Drugs Consumption and Growth Rate of Gastrointestinal Stromal Tumors (GIST) (2017-2022)
Table Global Imatinib Drugs Consumption and Growth Rate of Hyper-eosinophilic Syndrome (HES) (2017-2022)
Table Global Imatinib Drugs Consumption and Growth Rate of Myelodysplastic Syndrome (MDS) (2017-2022)
Table Global Imatinib Drugs Consumption and Growth Rate of Myeloproliferative Diseases (MPD) (2017-2022)
Table Global Imatinib Drugs Consumption and Growth Rate of Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia (Ph+ ALL) (2017-2022)
Table Global Imatinib Drugs Consumption and Growth Rate of Philadelphia Chromosome-positive Chronic Myeloid Leukemia (Ph+ CML) (2017-2022)
Figure Global Imatinib Drugs Sales Volume and Growth Rate Forecast (2022-2027)
Figure Global Imatinib Drugs Revenue (Million USD) and Growth Rate Forecast (2022-2027)
Figure Global Imatinib Drugs Price and Trend Forecast (2022-2027)
Figure USA Imatinib Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure USA Imatinib Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Imatinib Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Imatinib Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure China Imatinib Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure China Imatinib Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Imatinib Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Imatinib Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure India Imatinib Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure India Imatinib Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Imatinib Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Imatinib Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Imatinib Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Imatinib Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Imatinib Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Imatinib Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Table Global Imatinib Drugs Market Sales Volume Forecast, by Type
Table Global Imatinib Drugs Sales Volume Market Share Forecast, by Type
Table Global Imatinib Drugs Market Revenue (Million USD) Forecast, by Type
Table Global Imatinib Drugs Revenue Market Share Forecast, by Type
Table Global Imatinib Drugs Price Forecast, by Type
Figure Global Imatinib Drugs Revenue (Million USD) and Growth Rate of Capsules (2022-2027)
Figure Global Imatinib Drugs Revenue (Million USD) and Growth Rate of Capsules (2022-2027)
Figure Global Imatinib Drugs Revenue (Million USD) and Growth Rate of Tablets (2022-2027)
Figure Global Imatinib Drugs Revenue (Million USD) and Growth Rate of Tablets (2022-2027)
Table Global Imatinib Drugs Market Consumption Forecast, by Application
Table Global Imatinib Drugs Consumption Market Share Forecast, by Application
Table Global Imatinib Drugs Market Revenue (Million USD) Forecast, by Application
Table Global Imatinib Drugs Revenue Market Share Forecast, by Application
Figure Global Imatinib Drugs Consumption Value (Million USD) and Growth Rate of Aggressive Systemic Mastocytosis (ASM) (2022-2027)
Figure Global Imatinib Drugs Consumption Value (Million USD) and Growth Rate of Chronic Eosinophilic Leukemia (CEL) (2022-2027)
Figure Global Imatinib Drugs Consumption Value (Million USD) and Growth Rate of Dermatofibrosarcoma Protuberans (DFSP) (2022-2027)
Figure Global Imatinib Drugs Consumption Value (Million USD) and Growth Rate of Gastrointestinal Stromal Tumors (GIST) (2022-2027)
Figure Global Imatinib Drugs Consumption Value (Million USD) and Growth Rate of Hyper-eosinophilic Syndrome (HES) (2022-2027)
Figure Global Imatinib Drugs Consumption Value (Million USD) and Growth Rate of Myelodysplastic Syndrome (MDS) (2022-2027)
Figure Global Imatinib Drugs Consumption Value (Million USD) and Growth Rate of Myeloproliferative Diseases (MPD) (2022-2027)
Figure Global Imatinib Drugs Consumption Value (Million USD) and Growth Rate of Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia (Ph+ ALL) (2022-2027)
Figure Global Imatinib Drugs Consumption Value (Million USD) and Growth Rate of Philadelphia Chromosome-positive Chronic Myeloid Leukemia (Ph+ CML) (2022-2027)
Figure Imatinib Drugs Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Manufacturing Cost Structure Analysis
Table Alternative Product Analysis
Table Downstream Distributors
Table Downstream Buyers
Table Sanofi S.A. Profile
Table Sanofi S.A. Imatinib Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Sanofi S.A. Imatinib Drugs Sales Volume and Growth Rate
Figure Sanofi S.A. Revenue (Million USD) Market Share 2017-2022
Table Sun Pharmaceuticals Profile
Table Sun Pharmaceuticals Imatinib Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Sun Pharmaceuticals Imatinib Drugs Sales Volume and Growth Rate
Figure Sun Pharmaceuticals Revenue (Million USD) Market Share 2017-2022
Table Novartis Profile
Table Novartis Imatinib Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Novartis Imatinib Drugs Sales Volume and Growth Rate
Figure Novartis Revenue (Million USD) Market Share 2017-2022
Table Apotex Inc. Profile
Table Apotex Inc. Imatinib Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Apotex Inc. Imatinib Drugs Sales Volume and Growth Rate
Figure Apotex Inc. Revenue (Million USD) Market Share 2017-2022
Table Dr. Reddy's Laboratories Profile
Table Dr. Reddy's Laboratories Imatinib Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Dr. Reddy's Laboratories Imatinib Drugs Sales Volume and Growth Rate
Figure Dr. Reddy's Laboratories Revenue (Million USD) Market Share 2017-2022
Table Mylan Pharms Inc. Profile
Table Mylan Pharms Inc. Imatinib Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Mylan Pharms Inc. Imatinib Drugs Sales Volume and Growth Rate
Figure Mylan Pharms Inc. Revenue (Million USD) Market Share 2017-2022
Table Glenmark Pharmaceuticals Ltd. Profile
Table Glenmark Pharmaceuticals Ltd. Imatinib Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Glenmark Pharmaceuticals Ltd. Imatinib Drugs Sales Volume and Growth Rate
Figure Glenmark Pharmaceuticals Ltd. Revenue (Million USD) Market Share 2017-2022
Table Teva Pharmaceutical Industries Ltd. Profile
Table Teva Pharmaceutical Industries Ltd. Imatinib Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Teva Pharmaceutical Industries Ltd. Imatinib Drugs Sales Volume and Growth Rate
Figure Teva Pharmaceutical Industries Ltd. Revenue (Million USD) Market Share 2017-2022
Table Actavis Generics Profile
Table Actavis Generics Imatinib Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Actavis Generics Imatinib Drugs Sales Volume and Growth Rate
Figure Actavis Generics Revenue (Million USD) Market Share 2017-2022
Table Cipla Inc. Profile
Table Cipla Inc. Imatinib Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Cipla Inc. Imatinib Drugs Sales Volume and Growth Rate
Figure Cipla Inc. Revenue (Million USD) Market Share 2017-2022
Figure Imatinib Drugs Product Picture
Table Global Imatinib Drugs Market Sales Volume and CAGR (%) Comparison by Type
Table Imatinib Drugs Market Consumption (Sales Volume) Comparison by Application (2017-2027)
Figure Global Imatinib Drugs Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)
Figure United States Imatinib Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Europe Imatinib Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Imatinib Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Imatinib Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Imatinib Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Imatinib Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Latin America Imatinib Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Middle East and Africa Imatinib Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Global Imatinib Drugs Market Sales Volume Status and Outlook (2017-2027)
Table Global Macroeconomic Analysis
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Imatinib Drugs Industry Development
Table Global Imatinib Drugs Sales Volume by Player (2017-2022)
Table Global Imatinib Drugs Sales Volume Share by Player (2017-2022)
Figure Global Imatinib Drugs Sales Volume Share by Player in 2021
Table Imatinib Drugs Revenue (Million USD) by Player (2017-2022)
Table Imatinib Drugs Revenue Market Share by Player (2017-2022)
Table Imatinib Drugs Price by Player (2017-2022)
Table Imatinib Drugs Gross Margin by Player (2017-2022)
Table Mergers & Acquisitions, Expansion Plans
Table Global Imatinib Drugs Sales Volume, Region Wise (2017-2022)
Table Global Imatinib Drugs Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Imatinib Drugs Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Imatinib Drugs Sales Volume Market Share, Region Wise in 2021
Table Global Imatinib Drugs Revenue (Million USD), Region Wise (2017-2022)
Table Global Imatinib Drugs Revenue Market Share, Region Wise (2017-2022)
Figure Global Imatinib Drugs Revenue Market Share, Region Wise (2017-2022)
Figure Global Imatinib Drugs Revenue Market Share, Region Wise in 2021
Table Global Imatinib Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table United States Imatinib Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Europe Imatinib Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table China Imatinib Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Japan Imatinib Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table India Imatinib Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Southeast Asia Imatinib Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Latin America Imatinib Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Middle East and Africa Imatinib Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Global Imatinib Drugs Sales Volume by Type (2017-2022)
Table Global Imatinib Drugs Sales Volume Market Share by Type (2017-2022)
Figure Global Imatinib Drugs Sales Volume Market Share by Type in 2021
Table Global Imatinib Drugs Revenue (Million USD) by Type (2017-2022)
Table Global Imatinib Drugs Revenue Market Share by Type (2017-2022)
Figure Global Imatinib Drugs Revenue Market Share by Type in 2021
Table Imatinib Drugs Price by Type (2017-2022)
Figure Global Imatinib Drugs Sales Volume and Growth Rate of Capsules (2017-2022)
Figure Global Imatinib Drugs Revenue (Million USD) and Growth Rate of Capsules (2017-2022)
Figure Global Imatinib Drugs Sales Volume and Growth Rate of Tablets (2017-2022)
Figure Global Imatinib Drugs Revenue (Million USD) and Growth Rate of Tablets (2017-2022)
Table Global Imatinib Drugs Consumption by Application (2017-2022)
Table Global Imatinib Drugs Consumption Market Share by Application (2017-2022)
Table Global Imatinib Drugs Consumption Revenue (Million USD) by Application (2017-2022)
Table Global Imatinib Drugs Consumption Revenue Market Share by Application (2017-2022)
Table Global Imatinib Drugs Consumption and Growth Rate of Aggressive Systemic Mastocytosis (ASM) (2017-2022)
Table Global Imatinib Drugs Consumption and Growth Rate of Chronic Eosinophilic Leukemia (CEL) (2017-2022)
Table Global Imatinib Drugs Consumption and Growth Rate of Dermatofibrosarcoma Protuberans (DFSP) (2017-2022)
Table Global Imatinib Drugs Consumption and Growth Rate of Gastrointestinal Stromal Tumors (GIST) (2017-2022)
Table Global Imatinib Drugs Consumption and Growth Rate of Hyper-eosinophilic Syndrome (HES) (2017-2022)
Table Global Imatinib Drugs Consumption and Growth Rate of Myelodysplastic Syndrome (MDS) (2017-2022)
Table Global Imatinib Drugs Consumption and Growth Rate of Myeloproliferative Diseases (MPD) (2017-2022)
Table Global Imatinib Drugs Consumption and Growth Rate of Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia (Ph+ ALL) (2017-2022)
Table Global Imatinib Drugs Consumption and Growth Rate of Philadelphia Chromosome-positive Chronic Myeloid Leukemia (Ph+ CML) (2017-2022)
Figure Global Imatinib Drugs Sales Volume and Growth Rate Forecast (2022-2027)
Figure Global Imatinib Drugs Revenue (Million USD) and Growth Rate Forecast (2022-2027)
Figure Global Imatinib Drugs Price and Trend Forecast (2022-2027)
Figure USA Imatinib Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure USA Imatinib Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Imatinib Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Imatinib Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure China Imatinib Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure China Imatinib Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Imatinib Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Imatinib Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure India Imatinib Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure India Imatinib Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Imatinib Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Imatinib Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Imatinib Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Imatinib Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Imatinib Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Imatinib Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Table Global Imatinib Drugs Market Sales Volume Forecast, by Type
Table Global Imatinib Drugs Sales Volume Market Share Forecast, by Type
Table Global Imatinib Drugs Market Revenue (Million USD) Forecast, by Type
Table Global Imatinib Drugs Revenue Market Share Forecast, by Type
Table Global Imatinib Drugs Price Forecast, by Type
Figure Global Imatinib Drugs Revenue (Million USD) and Growth Rate of Capsules (2022-2027)
Figure Global Imatinib Drugs Revenue (Million USD) and Growth Rate of Capsules (2022-2027)
Figure Global Imatinib Drugs Revenue (Million USD) and Growth Rate of Tablets (2022-2027)
Figure Global Imatinib Drugs Revenue (Million USD) and Growth Rate of Tablets (2022-2027)
Table Global Imatinib Drugs Market Consumption Forecast, by Application
Table Global Imatinib Drugs Consumption Market Share Forecast, by Application
Table Global Imatinib Drugs Market Revenue (Million USD) Forecast, by Application
Table Global Imatinib Drugs Revenue Market Share Forecast, by Application
Figure Global Imatinib Drugs Consumption Value (Million USD) and Growth Rate of Aggressive Systemic Mastocytosis (ASM) (2022-2027)
Figure Global Imatinib Drugs Consumption Value (Million USD) and Growth Rate of Chronic Eosinophilic Leukemia (CEL) (2022-2027)
Figure Global Imatinib Drugs Consumption Value (Million USD) and Growth Rate of Dermatofibrosarcoma Protuberans (DFSP) (2022-2027)
Figure Global Imatinib Drugs Consumption Value (Million USD) and Growth Rate of Gastrointestinal Stromal Tumors (GIST) (2022-2027)
Figure Global Imatinib Drugs Consumption Value (Million USD) and Growth Rate of Hyper-eosinophilic Syndrome (HES) (2022-2027)
Figure Global Imatinib Drugs Consumption Value (Million USD) and Growth Rate of Myelodysplastic Syndrome (MDS) (2022-2027)
Figure Global Imatinib Drugs Consumption Value (Million USD) and Growth Rate of Myeloproliferative Diseases (MPD) (2022-2027)
Figure Global Imatinib Drugs Consumption Value (Million USD) and Growth Rate of Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia (Ph+ ALL) (2022-2027)
Figure Global Imatinib Drugs Consumption Value (Million USD) and Growth Rate of Philadelphia Chromosome-positive Chronic Myeloid Leukemia (Ph+ CML) (2022-2027)
Figure Imatinib Drugs Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Manufacturing Cost Structure Analysis
Table Alternative Product Analysis
Table Downstream Distributors
Table Downstream Buyers
Table Sanofi S.A. Profile
Table Sanofi S.A. Imatinib Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Sanofi S.A. Imatinib Drugs Sales Volume and Growth Rate
Figure Sanofi S.A. Revenue (Million USD) Market Share 2017-2022
Table Sun Pharmaceuticals Profile
Table Sun Pharmaceuticals Imatinib Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Sun Pharmaceuticals Imatinib Drugs Sales Volume and Growth Rate
Figure Sun Pharmaceuticals Revenue (Million USD) Market Share 2017-2022
Table Novartis Profile
Table Novartis Imatinib Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Novartis Imatinib Drugs Sales Volume and Growth Rate
Figure Novartis Revenue (Million USD) Market Share 2017-2022
Table Apotex Inc. Profile
Table Apotex Inc. Imatinib Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Apotex Inc. Imatinib Drugs Sales Volume and Growth Rate
Figure Apotex Inc. Revenue (Million USD) Market Share 2017-2022
Table Dr. Reddy's Laboratories Profile
Table Dr. Reddy's Laboratories Imatinib Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Dr. Reddy's Laboratories Imatinib Drugs Sales Volume and Growth Rate
Figure Dr. Reddy's Laboratories Revenue (Million USD) Market Share 2017-2022
Table Mylan Pharms Inc. Profile
Table Mylan Pharms Inc. Imatinib Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Mylan Pharms Inc. Imatinib Drugs Sales Volume and Growth Rate
Figure Mylan Pharms Inc. Revenue (Million USD) Market Share 2017-2022
Table Glenmark Pharmaceuticals Ltd. Profile
Table Glenmark Pharmaceuticals Ltd. Imatinib Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Glenmark Pharmaceuticals Ltd. Imatinib Drugs Sales Volume and Growth Rate
Figure Glenmark Pharmaceuticals Ltd. Revenue (Million USD) Market Share 2017-2022
Table Teva Pharmaceutical Industries Ltd. Profile
Table Teva Pharmaceutical Industries Ltd. Imatinib Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Teva Pharmaceutical Industries Ltd. Imatinib Drugs Sales Volume and Growth Rate
Figure Teva Pharmaceutical Industries Ltd. Revenue (Million USD) Market Share 2017-2022
Table Actavis Generics Profile
Table Actavis Generics Imatinib Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Actavis Generics Imatinib Drugs Sales Volume and Growth Rate
Figure Actavis Generics Revenue (Million USD) Market Share 2017-2022
Table Cipla Inc. Profile
Table Cipla Inc. Imatinib Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Cipla Inc. Imatinib Drugs Sales Volume and Growth Rate
Figure Cipla Inc. Revenue (Million USD) Market Share 2017-2022
